HRID568279

反应详情

EQUATION

反应方程式

HRID 568279 的结构方程式

AUXILIARIES

试剂、催化剂与溶剂

1

CONDITIONS

反应条件

温度
-50 °C

PROCEDURE

实验过程

A 2 M methylmagnesium iodide/diethyl ether solution (4.6 ml) is diluted with 50 ml of anhydrous THF, and a solution of 2.0 g of 7-iodoimidazo[5,1-b]thiazole in 50 ml of THF is added dropwise to the diluted solution under ice cooling in an argon atmosphere. The mixture is stirred at that temperature for 10 min and then at room temperature for 1.5 hr and cooled to −50° C., and a solution of 1.735 g of (3R,5S)-1-allyloxycarbonyl-3-t-butyldimethylsilyloxy-5-formylpyrrolidine in 50 ml of THF is added dropwise thereto. A reaction is allowed to proceed while raising the temperature to 10° C. over a period of 3 hr, 200 ml of a semi-saturated aqueous ammonium chloride solution is added thereto, and the mixture is extracted twice with 250 ml of ethyl acetate. The organic layer is dried over anhydrous magnesium sulfate and filtered, and the solvent is removed by evaporation. The residue is purified by column chromatography on silica gel (ethyl acetate alone→ethyl acetate:methanol=20:1→10:1). Thus, 450 mg of (3R,5S)-1-allyloxycarbonyl-3-t-butyldimethylsilyloxy-5-[1-hydroxy-1-(imidazo[5,1-b]thiazol-7-yl)methyl]pyrrolidine (stereoisomer A: a high polar component) and 395 mg of (3R,5S)-1-allyloxycarbonyl-3-t-butyldimethylsilyloxy-5-[l-hydroxy-1-(imidazo[5,1-b]thiazol-7-yl)methyl]pyrrolidine (stereoisomer B: a low polar component) are prepared.

WORKUP

后处理

  1. waitat room temperature for 1.5 hr
  2. temperaturewhile raising the temperature to 10° C. over a period of 3 hr
  3. extractionthe mixture is extracted twice with 250 ml of ethyl acetate
  4. dry with materialThe organic layer is dried over anhydrous magnesium sulfate
  5. filtrationfiltered
  6. customthe solvent is removed by evaporation
  7. customThe residue is purified by column chromatography on silica gel (ethyl acetate alone→ethyl acetate
  8. customThus, 450 mg of (3R,5S)-1-allyloxycarbonyl-3-t-butyldimethylsilyloxy-5-[1-hydroxy-1-(imidazo[5,1-b]thiazol-7-yl)methyl]pyrrolidine (stereoisomer A: a high polar component) and 395 mg of (3R,5S)-1-allyloxycarbonyl-3-t-butyldimethylsilyloxy-5-[l-hydroxy-1-(imidazo[5,1-b]thiazol-7-yl)methyl]pyrrolidine (stereoisomer B: a low polar component) are prepared